Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The process by which antigen-presenting cells (APCs) more effectively activate T cells through the presentation of polysaccharide antigens that have been chemically conjugated to carrier proteins. This conjugation enables processing and presentation of non-protein antigens via linked recognition, facilitating helper-T-cell engagement through presentation of carrier-derived peptides on MHCII, and ultimately leading to robust IgG production and immune memory.
Enhances antigen presentation and T cell activation by conjugating polysaccharide antigens to carrier proteins, enabling MHC II presentation of carrier-derived peptides and linked recognition by B cells.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antigen-presenting cell activation via enhanced presentation of conjugated polysaccharide antigens (carrier effect).